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Summary
Depletion of CD4+ cells using anti-CD4 monoclonal antibodies leads to allograft tolerance.
Here we show that anti-CD4-mediated tolerance to pancreatic islets of Langerhans transplanted
from an A/J (IEk) donor to a diabetic C57B1/6 (B6) (IE - ) recipient occurs in the absence of
clonal deletion of the potentially IE-reactive V#11+ T cells . Instead, a state of clonal anergy is
induced in both the CD4+Vs11+ and CD8+VR11+ T cell subsets. This clonal anergy can be
partially overcome in vitro by the addition of recombinant interleukin 2 .
T
cells play a central role in the rejection of allografted
tissue. We have previously demonstrated that adminis-
tration of depleting regimens of an anti-CD4 mAb at the
time of transplantation allows indefinite survival of islet (1)
and heart (2) allografts . The mechanisms involved in this in-
duced transplantation tolerance are not understood .
Several groups have shown that murine TCR V,6 gene
segments (i .e ., Vs5, V,s11, and V017) may encode reactivity
with the class IIMHC antigen IE ; therefore, mice expressing
III generate self-tolerance by deleting the majority of V05+,
V011+, and V#17' T cells from the periphery (3-6) . Adult-
induced tolerance may not be due to clonal deletion (7) but
may instead be mediated by clonal anergy (8) or suppression
(9) . Data presented in this report begin to address the role
of these peripheral mechanisms in anti-CD4-induced trans-
plantation tolerance.
Materials and Methods
Mice.
￿
Adult A/J, B6, and B10.A mice were bredin our depart-
mental animal facility. The transplantation protocol has been de-
scribed previously (1) .
FACS .
￿
The relativeT cell subset frequencies present in thePBL
of anti-CD4-treated and control mice were analyzed by FACS
(Becton Dickinson&Co., Mountain View, CA) analysis. PBL were
isolated on the indicated days by separation on a LympholyteM
(Cedarlane Laboratories, Ontario, Canada) gradient . CD4+Vs11'
T cells were analyzed using mAb to Voil (RR3-15 [5]), followed
by fluoresceinated goat anti-rat (mouse-adsorbed) Ig (Caltag Labora-
tories, San Francisco, CA) . The cells were washed, incubated in
50% normal rat serum to bind to remaining anti-rat Ig, and stained
with PE-conjugated anti-CD4(mAbGK1.5 ; Becton Dickinson Im-
munocytometry Systems, San Jose, CA) . CD4'V#8' T cells were
analyzed using fluoresceinated mAb to Vs8 (F23.1; [10]) followed
by PE-conjugated anti-CD4 . For anti-CD8 staining, biotinylated
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anti-Lyt-2 (mAb 53.6.7; Becton Dickinson & Co.) was used fol-
lowed by avidin-PE (Caltag Laboratories) . Cells were analyzed on
a modified dual laser FRCS with logarithmic amplifiers (Becton
Dickinson & Co.) .
Anti-TCR Activation Assay .
￿
T cell proliferation was induced by
receptor crosslinking with mAb specific for Vsli (RR3-15 [5]),
CD3 (1452C11 [111), Vs17 (KJ23 [3]), and Vo8 (F23.1 (101) .
U-bottomed microtiter plates (Flow Laboratories Inc., McLean VA)
were coated with the indicated antibody (10 P.g/ml) for 2-6 h at
37°C . Plates were washed twice in PBS, and 2 x 101 peripheral
LN cells were added per well . The plates were incubated for 4 d
(CD3) or 5 d (Vo17, Vs11, Vo8) with ['H]thymidine added for
the final 12-16 h of culture . For assays on spleen cells, RBC were
lysed by hypotonic shock . Where separated cell populations were
used, two separated aliquots ofcells were stained with either PE-
conjugated anti-CD4 mAb GK1.5 (for anti-CD4 depletion) or
fluoresceinated anti-CD8 mAb 53.6.7 (for anti-CD8 depletion) .
The cells were then negatively selected by sorting on a FACStar
plus . Theresulting CD4-depleted or CD8-depleted populations were
>99% pure as determined by FRCS analysis.
Results and Discussion
To study the potential mechanisms of transplantation toler-
ance mediated by depleting regimens of anti-CD4, donor and
recipient mice were selected so that the IE antigen was ex-
pressed only by the donor tissue . Pancreatic islets of Lang-
erhans were isolated from adult A/J (IEk) donors and trans-
planted into the livers of streptozotocin-induced diabetic B6
recipients as previously described (1) . B6 mice do not express
IE, thus, Vy11' T cells, which have been shown to respond
to IE alloantigens in vivo (12), are present in their periphery.
All diabetic mice that were given anti-CD4 antibody at the
time they received allogeneicA/J islets showed indefinite ac-
ceptance of their graft, as evidenced by persistent normogly-
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cemia (>200 d) . In contrast, diabetic recipients that received
allografts without anti-CD4 treatment rejected their islet al-
lografts .
To determine whether the transplantation tolerance induced
under this treatment regimen resulted from clonal deletion
of the potentially IE-reactiveT cells, we assayed lymphocytes
for the expression of a TCR VB that would have undergone
deletion in IE+ mice by FACS analysis using a mAb specific
for VB11 . mAb to V08 was used as a control since, in con-
trast to T cells expressing VB11, T cells expressing V08 are
not known to be deleted in mice expressing IE . Data presented
in Fig. 1 represent the repopulation kinetics ofGKL5+ cells
after treatment with 50 ,ug of the anti-CD4mAb GK1.5y2a
(13) on days -1, 0, and +1 relative to transplant, a dose that
depletes x+90% of the CD5+CD8- cells (14) . The kinetics
of repopulation of the CD4+VB11+ cells are comparable in
both the anti-CD4-treated nontransplanted group and the
Table 1 .
￿
Analysis of Transplanted Mice for Clonal Deletion of
B6 mice transplanted with A/J islets coincident with anti-CD4 adminis-
tration were analyzed 6 mo after being transplanted . Age-matched B6
mice serve as a positive control and B10.A mice give an indication of
the frequency of V,B11+ T cells expected when clonal deletion has oc-
curred. Staining was done as in Fig. 1, except that for CD8 staining,
biotinylated anti-CD8 mAb was used followed by avidin-PE . Percentages
represent the mean and SEM from five to six mice relative to total CD4+
plus CD8+ T cells .
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Figure 1 . Repopulation of CD4+Vp11+ (0) and
CD4+VB8+ (O) T cells in anti-CD4-treated nontrans-
planted (filled) vs . transplanted (open) mice . Mice were in-
jected intravenously three times with 50 jig GK1.5y2a
mAb on days -1, 0, and +1 relative to transplant . PBL
were isolated on the indicated days, and CD4+V011' T
cells were analyzed using mAb to VB11, followed by
fluoresceinated goat anti-rat Ig and PE-conjugated anti-
CD4. CD4'VB8+ T cells were analyzed using fluoresce-
inatedmAb to VB8 followed by PE-conjugated anti-CD4 .
Due to bound GK1.5y2a, nondepleted CD4+ cells are
not detecteduntil after day 4. Percentage ofcells staining
with theindicated antibodies is expressed relative to total
CD4+ plus CD8+ cells. Data represent one of two
similar experiments .
anti-CD4-treated transplanted group (Fig. 1), indicating that
the presence of an islet allograft from an IE+ donor did not
influence the repopulation kinetics of Vs11+ T cells in an
IE - recipient . Furthermore, there was no significant reduc-
tion in the frequency of Vs11+ (or Vo5 + ; data not shown)
T cells of allogra£ted animals 6mo post-treatment when com-
pared with untreated B6 mice (Table 1) . These data indicate
that anti-CD4-mediated transplantation tolerance is not due
to clonal deletion of potentially IE-reactive T cells.
We next asked whether T cells expressing the relevant Va
gene segments could be activated in response to antiTCR
specific crosslinking (Fig . 2) . As expected, LN cells from
normal B6 mice, B6 mice transplanted with A/J islets, and
normal B10.A mice showed good proliferation in response
to immobilized mAb to CD3, a determinant found on all
T cells. In contrast, LN cells from the transplanted mice
showed a greatly reduced response, relative to normal B6 mice,
when stimulated with immobilized mAb to Vo11 . The re-
sponse ofLN cells from eight of nine transplanted mice ap-
proximated that of the BIO.A mice, which have clonally deleted
most Vall + T cells, whereas the response of one of the
transplanted mice, while about fivefold greater than that of
the B10.A, was still -50% that of the control B6 mouse
(data not shown) . This decreased response is specific for the
VB11+ population, as the response o£ VB8+ T cells stimu-
lated with mAb to VB8 was comparable in normal B6 and
in transplanted mice (Fig . 2) .
To determine if the unresponsiveness seen in the transplanted
mice was found in either or both the CD4+Vs11+ or
CD8+Vs11+ T cell subsets, CD4-depleted and CD8-
depleted (>99% pure) populations were obtained from spleen
cells of transplanted and normal B6 mice by cell sorting and
were used in the antiTCR-mediated activation assay . The
results with unseparated spleen cells (Table 2A) were similar
to those with LN cells (Fig . 2) ; the Va11+ T cell popula-
tion from the transplanted mice showed little or no response
to antiVsll stimulation . When CD4-depleted and CD8-
depleted spleen cell populations from the transplanted mice
were used in the antiTCR activation assay, both displayed
minimal reactivity to anti-V,911 compared with the response
V,e11 + T Cells
Strain of Mouse
Stain B10.A B6 Transplant
CD4'VB1I+ 0.07 ± 0.03 3.0 ± 0.6 2 .6 ± 0.2
CD4+VB8+ 14.3 ± 3.3 15.9 ± 2.5 13 .4 ± 1 .4
CD8+V,sll' 1 .8 ± 0.1 3.3 ± 0.7 3 .6 ± 0.4
CD8+VB8+ 12.6 ± 3.4 9.0 ± 1 .0 9 .5 ± 0.4Table 2 .
￿
Anti-V#11 Response ofCD4-depleted (- CD4) and CD8-depleted (- CD8) Cells
T cell proliferation was induced by receptor crosslinking as described in Fig. 2 . For experiments using separated cells, two separated aliquots of
cells were stained with either PE-conjugated anti-CD4 mAb GK1 .5 (for anti-CD4 depletion) or fluoresceinated anti-CD8 mab 53.6.7 (for anti-CD8
depletion) and negatively selected by cell sorting. The resulting CD4-depleted or CD8-depleted populations were >99% pure as determined by FRCS
analysis . Data are expressed as the mean of triplicate wells in total cpm. Data represent one of three similar experiments .
ofthese populations from normal B6 mice (Table2B) . Mixing
C134-depleted cells from a responsive B6 mouse with CD8-
depleted cells from a transplanted mouse, or C134-depleted
cellsfrom a transplantedmousewith CD8-depleted cells from
a responsive B6 mouse, indicated that neitherpopulation from
the transplanted mouse could suppress the response of cells
from a normal mouse (Table 2 D) .
Previously, it hasbeen reported that T cell clones that have
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been rendered anergic do notproduce 1172 in response to TCR
occupancy despite the expression offunctional IL-2 receptors
(15) . We have also shown that rIL2 can partially reconstitute
the ability of Vo11+ T cells of transplanted mice to respond
to immobilized antiV,311 (Fig. 2), indicating that one de-
fect of the unresponsive Vg11 + T cell population may in-
clude the inability to produce IL2 .
The induced peripheral transplantation tolerance described
Figure 2 .
￿
Transplanted mice show a poor response to
specific anti V#11 stimulation . T cell proliferation was in-
duced by receptor crosslinking with mAb specific for
V,617 (negative control), Vp11, Vs8, and CD3 (positive
control) . Peripheral LN cells (2 x 105) were added per
well and the plates incubated for4d(CD3) or 5 d(VsV,
V,611, V#8) with (3H]thymidine added for the final 12-16h
of culture. For experiments with IIT2, 50 pl of rIL2 (50
U/ml ; Cetus Corp.) was added to the appropriate wells .
Data are expressed as the mean of triplicate wells in A
cpm with the background (cpm for V#17) subtracted .
Data represent one of nine similar experiments .
Responder No . of cells V,617
Proliferation
Vsll CD3
cpm
A B6 4 x 105 7,776 67,499 ND
2 x 105 3,402 26,405 ND
Transplant 4 x 105 8,370 7,259 ND
2 x 105 8,057 6,955 ND
B B6 (-CD8) 2 x 105 5,349 22,173 54,295
Transplant (-CD8) 2 x 105 5,897 7,189 38,086
B6 (-CD4) 2 x 105 1,908 20,217 68,058
Transplant (-CD4) 2 x 105 5,716 6,232 58,491
C B6 (-CD8) + B6 (-CD4) 2 x 105 each 7,671 53,100 44,060
105 each 7,093 23,274 49,816
Transplant (-CD8) + transplant (-CD4) 2 x 105 each 7,702 8,651 41,688
105 each 5,361 5,521 48,368
D B6 (-CD8) + transplant (-CD4) 2 x 105 each 8,156 20,067 37,170
Transplant (-CD8) + B6 (-CD4) 2 x 105 each ND 16,986 NDhere is similar to the clonal anergy described previously (16-18)
in several respects : (a) clonal deletion of the potentially IE-
reactive Vs11+ T cells did not occur; (b) the Vp11+ T cells
from the tolerant B6 mice showed agreatlyreducedresponse
relative to normal B6 mice when stimulated with immobi-
lizedmAb to Vs11 ; and (c) the unresponsiveness could be
partially overcome in vitroby the addition of rIL2 . Further-
more, the results presented here demonstrate that the unre-
sponsiveness to antiVg11 activation is found in both the
CD4+Vo11+ and CD8+V011+ T cell subsets. Finally, our
mixing experiments show that suppression of one subset of
tolerant cells by theotherdidnot occur. Taken together, these
results indicate that depletingregimens of anti-CD4 mediate
transplantation tolerance due to the induction ofclonal anergy
to alloantigen .
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